Details of the Drug Formulaction

General Information of Drug Formulation (ID: F04083)

Formulation Name
Chlorpromazine 50 mg tablet
Company
NCS HealthCare of KY, Inc dba Vangard Labs
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Beta-D-lactose E00099 6134 Diluent; Dry powder inhaler carrier; Lyophilization aid
Calcium sulfate anhydrous E00303 24497 Desiccant; Diluent
FD&C blue no. 2 E00446 2723854 Colorant
Ferrosoferric oxide E00231 14789 Colorant
Magnesium stearate E00208 11177 lubricant
methylparaben E00149 7456 Antimicrobial preservative
Propyl 4-hydroxybenzoate E00141 7175 Antimicrobial preservative
Quinoline yellow WS E00309 24671 Colorant
Saccharose E00091 5988 Binding agent; Coating agent; Cryoprotectant; Diluent; Flavoring agent; Suspending agent; Viscosity-controlling agent
Sodium benzoate E00432 517055 Antimicrobial preservative; lubricant
Sunset yellow FCF E00255 17730 Colorant
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent